Tapewire

Nasdaq · USD

MGX

Metagenomi Therapeutics, Inc.

Export transactions ↓
Tapewire entity
7270
SEC CIK
0001785279
Parsed reports
73

Last 12 months

Inside the activity.

2 purchase rows · 13 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202504
Jan 202600
Feb 202600
Mar 202603
Apr 202600
May 202600
Jun 202603
Jul 202600
Aug 202600
Sep 202623
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 09, 2024 Filed Feb 16, 2024 01:38 UTC PurchaseCOMMON STOCK 100,000 $10.25 $1,025,000.00
Disclosure

SEC source: 0001209191-24-003423 · doc4.xml · nonDerivative · entry 1

Novo Holdings A/S · CIK 0001388325 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.